Livforsakringsbolaget Skandia Omsesidigt bought a new stake in Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 1,100 shares of the company’s stock, valued at approximately $34,000.
A number of other large investors have also added to or reduced their stakes in the company. Covestor Ltd grew its position in shares of Celsius by 12.9% in the 1st quarter. Covestor Ltd now owns 1,110 shares of the company’s stock worth $92,000 after buying an additional 127 shares during the last quarter. Moody National Bank Trust Division increased its position in shares of Celsius by 1.1% during the second quarter. Moody National Bank Trust Division now owns 17,122 shares of the company’s stock worth $977,000 after purchasing an additional 181 shares in the last quarter. Bleakley Financial Group LLC lifted its holdings in shares of Celsius by 1.2% during the 1st quarter. Bleakley Financial Group LLC now owns 18,557 shares of the company’s stock valued at $1,539,000 after purchasing an additional 215 shares during the last quarter. Tidal Investments LLC boosted its position in shares of Celsius by 4.3% in the 1st quarter. Tidal Investments LLC now owns 6,025 shares of the company’s stock worth $500,000 after purchasing an additional 249 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in Celsius by 62.5% during the 1st quarter. GAMMA Investing LLC now owns 689 shares of the company’s stock worth $57,000 after buying an additional 265 shares during the last quarter. 60.95% of the stock is currently owned by institutional investors.
Celsius Trading Down 1.1 %
Shares of NASDAQ:CELH opened at $33.78 on Thursday. Celsius Holdings, Inc. has a 12-month low of $28.20 and a 12-month high of $99.62. The business has a 50 day moving average of $34.98 and a two-hundred day moving average of $56.53. The company has a market capitalization of $7.87 billion, a PE ratio of 37.12, a PEG ratio of 2.29 and a beta of 1.84.
Analysts Set New Price Targets
Several equities research analysts have weighed in on CELH shares. TD Cowen lowered their price target on Celsius from $68.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Roth Mkm dropped their target price on shares of Celsius from $45.00 to $43.00 and set a “buy” rating on the stock in a research report on Friday, September 27th. Bank of America decreased their price target on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating for the company in a report on Thursday, September 5th. BNP Paribas started coverage on shares of Celsius in a report on Monday, June 24th. They set an “outperform” rating and a $87.00 price objective on the stock. Finally, Jefferies Financial Group reduced their target price on Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research note on Thursday, October 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, Celsius has a consensus rating of “Moderate Buy” and an average price target of $57.29.
Get Our Latest Analysis on Celsius
Insider Transactions at Celsius
In related news, CEO John Fieldly sold 74,847 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the transaction, the chief executive officer now owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.20% of the company’s stock.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
- Five stocks we like better than Celsius
- Investing In Automotive Stocks
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Use the MarketBeat Excel Dividend Calculator
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Buy P&G Now, Before It Sets A New All-Time High
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.